iqvia glp-1 prescriptions q3 2024 semaglutide tirzepatide iqvia glp-1 prescriptions semaglutide tirzepatide q3 2024 Ground News The Industrialization of Exceptions: When

Studies have shown that resistance training can be effective to maintain muscle mass during weight loss in people with obesity or overweight

These groundbreaking medications have garnered attention for their remarkable efficacy in reducing body weight and addressing obesity-related comorbidities, such as type 2 diabetes, high blood pressure, and high cholesterol

This heightened prevalence of anxiety among women can significantly impact sleep quality

Hair loss is not listed as a top adverse effect of GLP-1 receptor agonists, but both clinical trials and real-world experiences suggest it does occur in a minority of users